The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Lutetium-177-PSMA-617 in oligo-metastatic hormone sensitive prostate cancer (BULLSEYE trial).
 
Bastiaan Privé
Research Funding - ABX advanced biochemical compounds.; Novartis
 
Walter Noordzij
No Relationships to Disclose
 
Constantijn Muselaers
No Relationships to Disclose
 
Igle Jan de Jong
No Relationships to Disclose
 
Inge van Oort
No Relationships to Disclose
 
Marcel Janssen
No Relationships to Disclose
 
Bart Timmermans
No Relationships to Disclose
 
Michel de Groot
No Relationships to Disclose
 
Niven Mehra
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Janssen-Cilag; MSD Oncology (Inst); Pfizer
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); AstraZeneca/Merck (Inst); Bristol Myers Squibb Foundation (Inst); Janssen-Cilag (Inst)
 
Winald Gerritsen
Consulting or Advisory Role - Bayer; coretag; MSD Oncology; Novartis; ORCA Therapeutics
Expert Testimony - Astellas Medivation
 
Marianne Jonker
No Relationships to Disclose
 
Emmanouil Alevroudis
No Relationships to Disclose
 
Suzanne van der Gaag
No Relationships to Disclose
 
Jourik Gietema
Research Funding - Abbvie (Inst); Roche/Genentech (Inst); Siemens (Inst)
 
Michiel Sedelaar
No Relationships to Disclose
 
André Vis
No Relationships to Disclose
 
Alexis Vrachimis
No Relationships to Disclose
 
Daniela Oprea-Lager
No Relationships to Disclose
 
James Nagarajah
Research Funding - ABX advanced biochemical compounds.; Novartis; Voximetry